|Apolipoprotein B (Apo B)|
|Request package insert information
The assay has a linear range of 3.6 – 240 mg/dL with good correlation with existing FDA approved product with r2 values >0.99. The Diazyme Apo B Assay is not interfered by the following substances at the indicated concentrations: triglycerides at 1000 mg/dL, ascorbic acid at 10 mM, bilirubin at 40 mg/dL, bilirubin conjugate at 40 mg/dL, and hemoglobin at 1000 mg/dL. The reagent is stable for 18 months from date of manufacture when stored at 2°-8°C.
This method is based on the reaction of a sample containing human Apo B and a specific antiserum to form an insoluble complex which can be measured turbidimetrically at 340 nm. By constructing a standard curve from the absorbance of standards the concentration of apo B in the samples can be determined.
The Diazyme Apolipoprotein B Assay is intended for the quantitative in vitro determination of apolipoprotein B (Apo B) in serum. It can be used as an aid for assessing the risk of coronary artery disease. For in vitro diagnostic use.
|Kit (1120 Tests)||DZ142A-K||R1: 4 x 70 mL
R2: 2 x 50 mL
|Calibrator||DZ141A-Cal||1 x 1 mL|
|Control||DZ138A-Con||3 x 3 mL|